Improved Visceral Fat and Cardiometabolic Markers Retatrutide is likely to have superior effects on: Triglyceride levels LDL particle size and ApoB Insulin resistance (HOMA-IR) In patients with obesity, reduction of visceral fat is more critical than just total weight
Participants were randomized to placebo or retatrutide at 1 mg, 4 mg (dose-escalation), 4 mg (no escalation), 8 mg (escalation), 8 mg (no escalation), or 12 mg (escalation) for 48 weeks, following a slow titration protocol
We keep many Standard Process supplements in stock at our clinic, so you can pick them up when appropriate
Metabolic and Cardiovascular Effects Mild increase in heart rate has been observed in some patients
If you are already taking a GLP-1 medication, read our article on important Tips for Success While Taking Weight Loss Meds
But theres no clinical evidence that these patches actually work